Yaqob Samir Taleb

Dr. Yaqob Samir Taleb


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024
Verified
Journal Article
Open access
PDF file
YTYaqob Samir Taleb
Yaqob Samir Taleb
PMParas Memon
Paras Memon
AJAftab Jalbani
Aftab Jalbani
NANouf Al-Mutairi
Nouf Al-Mutairi
SASarah Al-Mukhaylid
Sarah Al-Mukhaylid
ZIZafar Iqbal
Zafar Iqbal
Inherited cardiomyopathies are a diverse group of heart muscle diseases caused by genetic mutations that result in structural and functional abnormalities of the myocardium. Understanding genotype-phenotype correlations in these conditions is vital for personalized cardiac medicine, enabling targeted therapeutic strategies and predictive diagnostics. This review explores the major types of inherited cardiomyopathies: Hypertrophic Cardiomyopathy (HCM), Dilated Cardiomyopathy (DCM), Arrhythmogenic Cardiomyopathy (ACM) and Restrictive Cardiomyopathy (RCM) and provides detailed insights into how different genetic mutations manifest as clinical features. The integration of multi-omics approaches and advanced disease modelling techniques has enhanced our ability to dissect these correlations. The review also discusses the implications of these findings for personalized medicine, including tailored therapeutic strategies, predictive diagnostics, and future research directions. Keywords Cardiomyopathy; Multi-omics techniques; Personalized medicine; Genetic testing

1 January 2025 in Saudi Journal for Health Sciences
Verified
Journal Article
Open access
YTYaqob Samir Taleb
Yaqob Samir Taleb
PMParas Memon
Paras Memon
AJAftab Jalbani
Aftab Jalbani
NANawaf Al-Anazi
Nawaf Al-Anazi
AAAbdulkareem Al-Garni
Abdulkareem Al-Garni
ZIZafar Iqbal
Zafar Iqbal
Inherited cardiomyopathies are a diverse group of heart muscle diseases caused by genetic mutations that result in structural and functional abnormalities of the myocardium. Understanding genotype–phenotype correlations in these conditions is vital for personalized cardiac medicine, enabling targeted therapeutic strategies and predictive diagnostics. This review explores the major types of inherited cardiomyopathies–hypertrophic cardiomyopathy, dilated cardiomyopathy, arrhythmogenic cardiomyopathy, and restrictive cardiomyopathy–and provides detailed insights into how different genetic mutations manifest as clinical features. The integration of multi-omics approaches and advanced disease modeling techniques has enhanced our ability to dissect these correlations. The review also discusses the implications of these findings for personalized medicine, including tailored therapeutic strategies, predictive diagnostics, and future research directions. JOURNAL/sjfhs/04.03/01772839-202501000-00004/figure1/v/2026-04-23T120233Z/r/image-tiff

29 April 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
LALubna Alnaim
Lubna Alnaim
AAAbdulkareem AlGarni
Abdulkareem AlGarni
Azfar IshaquiAzfar Ishaqui
Azfar Ishaqui
SASultan Alqahtani
Sultan Alqahtani
MAMuhammad Alshuaibi
Muhammad Alshuaibi
ZIZafar Iqbal
Zafar Iqbal
Cancer is increasingly recognized as a metabolic disease influenced by nutritional factors, with multi-omics technologies and artificial intelligence (AI), particularly machine learning (ML), enabling integrative analyses of diet, metabolism, and tumor biology interactions. This study aimed to synthesize evidence on these approaches for understanding the nutrition–metabolism–cancer axis and assess their translational potential in oncology, especially in low-resource settings. A PRISMA-compliant systematic review and meta-analysis searched PubMed, EMBASE, and Cochrane databases from 2018 to 2025, including studies on human cancers using ≥2 omics layers integrated via AI/ML and addressing nutritional/metabolic exposures. Random-effects pooling evaluated area under the curve (AUC), odds ratios (OR), and clinical endpoints, with subgroup analyses and quality assessments via QUADAS-2, ROBINS-I, TRIPOD, and PRISMA-AI. From 4812 records, 42 studies were included, yielding a pooled AUC of 0.88 (95% CI: 0.86–0.91) and OR of 2.4 (95% CI: 1.2–3.5), demonstrating encouraging but early-stage exploratory evidence of predictive performance. Cancer-specific signatures emerged in colorectal, breast, pancreatic, liver, and hematologic malignancies. A conceptual translational framework was proposed, integrating nutrition, omics, AI/ML, and oncology to illustrate a potential implementation pathway for developing countries like Saudi Arabia. These findings represent preliminary, hypothesis-generating evidence; the proposed framework requires prospective validation before clinical deployment, particularly in resource-limited settings.

9 August 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
YTYaqob Samir Taleb
Yaqob Samir Taleb
PMParas Memon
Paras Memon
AJAftab Ahmed Jalbani
Aftab Ahmed Jalbani
NANouf AlMutairi
Nouf AlMutairi
SMSarah Al Mukhaylid
Sarah Al Mukhaylid
ZIZafar Iqbal
Zafar Iqbal
Inherited cardiomyopathies are a diverse group of heart muscle diseases caused by genetic mutations that result in structural and functional abnormalities of the myocardium. Understanding genotype-phenotype correlations in these conditions is vital for personalized cardiac medicine, enabling targeted therapeutic strategies and predictive diagnostics. This review explores the major types of inherited cardiomyopathies—hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), arrhythmogenic right ventricular cardiomyopathy (ARVC), and restrictive cardiomyopathy (RCM)—and provides detailed insights into how different genetic mutations manifest as clinical features. The integration of multi-omics approaches and advanced disease modeling techniques has enhanced our ability to dissect these correlations. The review also discusses the implications of these findings for personalized medicine, including tailored therapeutic strategies, predictive diagnostics, and future research directions.

1 January 2024
Verified
Journal Article
Open access
PDF file
YTYaqob Samir Taleb
Yaqob Samir Taleb
PMParas Memon
Paras Memon
AJAftab Jalbani
Aftab Jalbani
NANouf Al-Mutairi
Nouf Al-Mutairi
SASarah Al-Mukhaylid
Sarah Al-Mukhaylid
ZIZafar Iqbal
Zafar Iqbal
Inherited cardiomyopathies are a diverse group of heart muscle diseases caused by genetic mutations that result in structural and functional abnormalities of the myocardium. Understanding genotype-phenotype correlations in these conditions is vital for personalized cardiac medicine, enabling targeted therapeutic strategies and predictive diagnostics. This review explores the major types of inherited cardiomyopathies: Hypertrophic Cardiomyopathy (HCM), Dilated Cardiomyopathy (DCM), Arrhythmogenic Cardiomyopathy (ACM) and Restrictive Cardiomyopathy (RCM) and provides detailed insights into how different genetic mutations manifest as clinical features. The integration of multi-omics approaches and advanced disease modelling techniques has enhanced our ability to dissect these correlations. The review also discusses the implications of these findings for personalized medicine, including tailored therapeutic strategies, predictive diagnostics, and future research directions. Keywords Cardiomyopathy; Multi-omics techniques; Personalized medicine; Genetic testing